Funder: National Institutes of Health

Due Dates: June 18, 2025 (New/Renewal/Resubmission/Revision) | August 21, 2025 (AIDS) | October 21, 2025 (New/Renewal/Resubmission/Revision) | December 22, 2025 (AIDS) | February 11, 2026 (New/Renewal/Resubmission/Revision) | April 21, 2026 (AIDS) | June 18, 2026 (New/Renewal/Resubmission/Revision) | August 21, 2026 (AIDS) | October 21, 2026 (New/Renewal/Resubmission/Revision) | December 23, 2026 (AIDS) | February 11, 2027 (New/Renewal/Resubmission/Revision) | April 23, 2027 (AIDS) | June 17, 2027 (New/Renewal/Resubmission/Revision) | August 23, 2027 (AIDS) | October 21, 2027 (New/Renewal/Resubmission/Revision) | December 23, 2027 (AIDS)

Funding Amounts: Up to $300,000 direct costs per year for up to 2 years; minimum 0.25:1 non-federal cost match required.

Summary: Supports optimization and validation of medical device prototypes, diagnostics, and research tools for heart, lung, blood, and sleep (HLBS) diseases; clinical trials are not allowed.

Key Information: Requires a letter of support from an Accelerator Partner and a cost-matching commitment; applications without these will not be reviewed.